| DC isoketal-modified proteins activate T cells and promote hypertension A Kirabo, V Fontana, APC De Faria, R Loperena, CL Galindo, J Wu, ... The Journal of clinical investigation 124 (10), 4642-4656, 2014 | 570 | 2014 |
| White coat syndrome and its variations: differences and clinical impact MR Pioli, AMV Ritter, AP de Faria, R Modolo Integrated blood pressure control, 73-79, 2018 | 144 | 2018 |
| Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers NR Barbaro, V Fontana, R Modolo, AP De Faria, AR Sabbatini, ... Blood pressure 24 (1), 7-13, 2015 | 127 | 2015 |
| Vascular stiffness and endothelial dysfunction: Correlations at different levels of blood pressure VN Figueiredo, JC Yugar-Toledo, LC Martins, LB Martins, APC de Faria, ... Blood pressure 21 (1), 31-38, 2012 | 118 | 2012 |
| High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension C de Haro Moraes, VN Figueiredo, APC De Faria, NR Barbaro, ... Journal of human hypertension 27 (4), 225-230, 2013 | 59 | 2013 |
| Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension APC de Faria, C Demacq, VN Figueiredo, CH Moraes, RC Santos, ... Hypertension Research 36 (12), 1067-1072, 2013 | 58 | 2013 |
| Refractory and resistant hypertension: characteristics and differences observed in a specialized clinic R Modolo, AP de Faria, AR Sabbatini, NR Barbaro, AMV Ritter, H Moreno Journal of the American Society of Hypertension 9 (5), 397-402, 2015 | 56 | 2015 |
| Deregulation of adipokines related to target organ damage on resistant hypertension AR Sabbatini, AP Faria, NR Barbaro, WM Gordo, RGP Modolo, C Pinho, ... Journal of human hypertension 28 (6), 388-392, 2014 | 55 | 2014 |
| Adipokines: novel players in resistant hypertension AP De Faria, R Modolo, V Fontana, H Moreno The Journal of Clinical Hypertension 16 (10), 754-759, 2014 | 51 | 2014 |
| Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists JC Yugar-Toledo, R Modolo, AP de Faria, H Moreno Vascular health and risk management, 403-411, 2017 | 48 | 2017 |
| Metabolic syndrome-related features in controlled and resistant hypertensive subjects AS Catharina, R Modolo, AMV Ritter, AR Sabbatini, HF Lopes, ... Arquivos brasileiros de cardiologia 110, 514-521, 2018 | 45 | 2018 |
| Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus B Moreno, AP de Faria, AMV Ritter, LBT Yugar, SE Ferreira‐Melo, ... The Journal of Clinical Hypertension 20 (5), 910-917, 2018 | 43 | 2018 |
| Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension APC de Faria, V Fontana, R Modolo, NR Barbaro, AR Sabbatini, ... Clinica Chimica Acta 433, 179-183, 2014 | 41 | 2014 |
| Combined aerobic and resistance exercises evokes longer reductions on ambulatory blood pressure in resistant hypertension: a randomized crossover trial NF Pires, HJ Coelho-Júnior, BB Gambassi, APC de Faria, AMV Ritter, ... Cardiovascular therapeutics 2020 (1), 8157858, 2020 | 40 | 2020 |
| Pro-inflammatory cytokines and resistant hypertension: potential for novel treatments? MR Pioli, AP de Faria Current hypertension reports 21, 1-8, 2019 | 36 | 2019 |
| Modulation of aldosterone levels by− 344 C/T CYP11B2 polymorphism and spironolactone use in resistant hypertension V Fontana, APC de Faria, NR Barbaro, AR Sabbatini, R Modolo, ... Journal of the American Society of Hypertension 8 (3), 146-151, 2014 | 36 | 2014 |
| Crosstalk between obesity and MMP-9 in cardiac remodelling–a cross-sectional study in apparent treatment-resistant hypertension AMV Ritter, AP de Faria, N Barbaro, AR Sabbatini, NB Correa, V Brunelli, ... Blood pressure 26 (2), 122-129, 2017 | 30 | 2017 |
| Resistant or refractory hypertension: are they different? R Modolo, AP de Faria, A Almeida, H Moreno Current hypertension reports 16, 1-7, 2014 | 30 | 2014 |
| Effects of angiotensin‐converting enzyme inhibition on leptin and adiponectin levels in essential hypertension V Fontana, APC de Faria, GH Oliveira‐Paula, PS Silva, C Biagi, ... Basic & clinical pharmacology & toxicology 114 (6), 472-475, 2014 | 30 | 2014 |
| A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension NB Correa, AP de Faria, AMV Ritter, AR Sabbatini, A Almeida, V Brunelli, ... Journal of the American Society of Hypertension 10 (6), 510-516. e1, 2016 | 29 | 2016 |
Rodrigo ModoloDepartment of Cardiology - AMC - Amsterdam / University of Campinas - UNICAMPBestätigte E-Mail-Adresse bei cardiol.br